0.010
0.000
(0.00%)
Nov 29 - Close
ASX
data delayed by 20 mins -
Disclaimer
Currency in AUD
| Range | - |
| 52 week | 0.01 - 0.03 |
| Open | - |
| Vol. | 0.00 |
| Mkt cap | 601,552.00 |
| P/E | - |
| Div/yield | - |
| EPS | -0.01 |
| Shares | 60.16M |
| Beta | - |
| Inst. own | - |
Events
Feb 25, 2013
Interim 2013 Telesso Technologies Ltd Earnings Release
|
|
Key stats and ratios
| Q4 (Dec '12) | 2012 | |
| Net profit margin | -2014.85% | -477.50% |
| Operating margin | -2014.85% | -477.49% |
| EBITD margin | - | -477.49% |
| Return on average assets | -98.45% | -24.63% |
| Return on average equity | -114.77% | -26.63% |
| Employees | 6 | - |
| Carbon Disclosure Rating | - | - |
Address
C/- Altus Financial Pty Limited Level 12, 10 Spring Street
SYDNEY, NSW 2000
Australia
+61-2-89083444 (Phone)
+61-2-89083455 (Fax)
SYDNEY, NSW 2000
Australia
+61-2-89083444 (Phone)
+61-2-89083455 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
Telesso Technologies Limited is an Australia-based company. As of June 30, 2012, the Company is focused on the ongoing review of new business opportunities. The Company operates in a single business segment, which includes biotechnology research and development. As of June 30, 2012, the Company is focused on investment opportunities. The Company continues to maintain its investment in Vascular Pathways Inc. (VPI).
Officers and directors
| Ian A. Atkin | Chief Financial Executive, Company Secretary | |
| Michael John Hoy | Non-Executive Chairman of the Board | |
| Cherrell Hirst | Director | |
| Lawrence Gozlan | Non-Executive Director | |
| Ross Alexander Macdonald Ph.D. | Non-Executive Director |